Predicting the public health impact of a malaria transmission-blocking vaccine

Public Health Interventions Blocking (statistics) Vaccine efficacy
DOI: 10.1038/s41467-021-21775-3 Publication Date: 2021-03-08T11:03:05Z
ABSTRACT
Abstract Transmission-blocking vaccines that interrupt malaria transmission from humans to mosquitoes are being tested in early clinical trials. The activity of such a vaccine is commonly evaluated using membrane-feeding assays. Understanding the field efficacy requires knowledge how heavily infected wild, naturally blood-fed are, as this indicates difficult it will be block transmission. Here we use data on collected Burkina Faso translate laboratory-estimated into an estimated field. A dynamics model then utilised predict transmission-blocking vaccine’s public health impact alongside existing interventions. suggests school-aged children attractive population target for vaccination. Benefits vaccination distributed across population, averting greatest number cases younger children. Utilising interventions could have substantial against malaria.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (51)
CITATIONS (27)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....